Technological Innovation and Digital Transformation in the Clinical Oncology Next Generation Sequencing Market
The genomic oncology industry is experiencing a technological renaissance, driven by advances in sequencing technology, artificial intelligence, and digital health. The Clinical Oncology Next Generation Sequencing NGS Market is at the forefront of these innovations, valued at USD 7.32 billion in 2025 and projected to reach USD 20 billion by 2035 at a CAGR of 10.6%. This article...
0 Comments 0 Shares 184 Views 0 Reviews